Don’t take our word for it. Read testimonials from international veterinarian’s about their experiences of using Arthramid Vet for the management of joint lameness. Or feel free to contact one of our veterinarians to share your own experiences, or if you have any questions for our panel of veterinary experts.
Testimonials From Clinical Practice
Dr Marcus Allan, New Zealand
Dr Kim McKellar, Australia
Dr Marc Koene, Germany
I was one of the first vets to use Arthramid worldwide and the results are quite astonishing” (read full)
Dr Florent David
I have been using Arthramid Vet for five years. I see lame horses that I qualify as “non-responders”. The diagnosis/localisation of pain is accurate on those cases, but they do not respond to rest, and corticosteroids +/- HA intrasynovial. These represent my biggest challenge. Arthramid Vet is often of great help on those cases in association with orthopaedic shoeing, magnetic diathermy and a revisited exercise program to regain and maintain soundness.
The second set of cases that represent a challenge are horses presented with poor performance. They are not genuinely lame, but several sites in their body including joints show signs of wear and tear. This accumulation of stress is associated with the athletic activity they perform and also to some individual predispositions to injury (poor conformation, overweight, lack of repair capacities). On these cases, Arthramid Vet for its long duration of action can help.
The third group of horses I see as a challenge are diagnosed with soft tissue injuries within synovial structures (tendon sheath, bursa or joint). In general, the body responds poorly to healing those lesions. It is still unclear to me if Arthramid Vet can help to return some of these horses to soundness when unsatisfactory healing of intrasynovial soft tissue has occurred.
Arthramid Vet is a very potent and very safe drug to use, and I recommend it to my clients and other vets. Arthramid Vet should be in the therapeutic toolbox of any equine veterinarian. I see Arthramid Vet as a solution with great potential, and more work is needed to refine its use.
Dr Stuart Vallance
BVSc (hons) Dip. ACVS
Specialist Equine Surgeon (VPB 5894), Advantage Equine Veterinary Practice,
Ascot Vale, VIC, Australia
My involvement with 2.5% PAAG Gel (Arthramid Vet) began in 2014 with a visit to the manufacturing factory in Copenhagen. I met with the lead scientists whom shared their early research and was reassured in the quality and consistency of the product after touring the human approved production facility.
I have utilised hundreds of doses of 2.5% PAAG gel since 2014, and during this period I have learnt how to maximise its benefit in my caseload of predominantly Thoroughbred racehorses. In my opinion, it can minimise the use of intra-articular corticosteroids or other joint therapies used in Thoroughbred stables. 2.5% PAAG is not a cortisone and shouldn’t be expected to diminish acute inflammation like corticosteroids do. In my opinion, it appears to have the greatest clinical effect in appropriately diagnosed joints with low-grade performance limiting lameness that are treated early in the horse’s preparation, or if utilised within a preparation given time (approximately 3 weeks) before one would expect to see a marked clinical improvement. In my caseload, the clinical effect can diminish after approximately 6 months, and I have administered multiple doses in the same joint over a number of years.
The treatment appears safe, and after seeing the manufacturing process I have very rarely concurrently utilised intra-articular antibiotics. The joints can have a mild increase in effusion post-treatment and this usually subsides over the coming weeks. I have very rarely experienced an intra-articular flare response but have learnt to stay calm during this process as they tend to respond to systemic anti-inflammatories, anti-microbial coverage and local cold-therapy.
Dr Marcus Allan
Arthramid Vet has achieved results that I thought were not possible and has therefore become a regular recommendation to owners to treat their horses with osteoarthritis when appropriate.
Dr Kim Mckellar
Dr Marc Koene
Arthramid Vet New Zealand
Registered in New Zealand to: Innovative Medical Solutions Limited NZBN: 9429041325544, 32 Hill Road, Cambridge 3494, New Zealand. Registered pursuant to the ACVM Act 1997 Number A11596. See www.foodsafety.govt.nz for registration conditions.